Drug
Biguanides clinical trials
- studies test it
- 4
- open now
- 0
- in phase 3
- 3
- first study started
- 2000
How studies write it
Studies that test it under each name
Name
Combined with it in one product
Studies by the year they started
4 studies that test it; most in 2013 (2)
| Year | Studies |
|---|---|
| 2000 | 1 |
| 2013 | 2 |
| 2021 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 3
- 3
- No phase
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 3 · Other 1
GlaxoSmithKline (1) · University of Pittsburgh (1) · Sanofi (1) · Metabolic Research Unit (1)
Often tested with
Tested in the same studies.
Sulfonylurea Antidiabetic Agent (2) · N,N''-sulfonylbis-urea (2) · 2,4-thiazolidinedione (1) · Glycoside Hydrolase Inhibitors (1) · Thiazolidinediones (1) · Insulin (1) · Dipeptidyl-Peptidase IV Inhibitors (1) · Sodium-Glucose Transporter 2 Inhibitors (1)
Studies
Open first, then newest update. How each study uses Biguanides is read from its arms, and is right about nine times in ten.
Testing it · 4
- ORAL ANTIDIABETICS EFFECT ON VISCERAL FATStatus unknownNot applicableMetabolic Research UnitNCT05032001Written as Biguanide, DPP4 inhibitors, SGLT2 inhibitors
- A Study to Determine the Long Term Safety and Efficacy of Albiglutide in Combination With Oral Monotherapy Antihyperglycemic Medications in Japanese Patients With Type 2 Diabetes MellitusCompletedPhase 3GlaxoSmithKlineNCT01777282Written as Biguanide
- Bypass Angioplasty Revascularization Investigation in Type 2 DiabetesCompletedPhase 3University of PittsburghNCT00006305Written as Biguanides, thiazolidinediones
- Safety and Tolerability of Lixisenatide in Combination With Oral Anti-Diabetic Treatment in Patients With Type 2 DiabetesCompletedPhase 3SanofiNCT01940965Written as biguanide
Given in every arm · 4 — Biguanides is usual care beside what is tested
- Long-term Safety Study of MP-513 in Patients With Type 2 DiabetesCompletedPhase 3Tanabe Pharma CorporationNCT01301833Written as biguanide
- A Study Comparing Insulin Peglispro With Insulin Glargine as Basal Insulin TreatmentCompletedPhase 3Eli Lilly and CompanyNCT01894568Written as Oral Antihyperglycemic Medications (OAMs)
- A Study of LY2189265 in Japanese Participants With Type 2 Diabetes MellitusCompletedPhase 3Eli Lilly and CompanyNCT01468181Written as Biguanides (BG)
- A Study of Dulaglutide in Japanese Participants With Type 2 Diabetes MellitusCompletedPhase 3Eli Lilly and CompanyNCT01584232Written as Biguanide (BG)
Codes
What other systems call Biguanides · ClinicalTrials.gg INT007073
- MeSH (NLM) D001645BiguanidesOne source ClinicalTrials.gov
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D001645 | Biguanides | One source ClinicalTrials.gov |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.